Hypertensive Disorders of Pregnancy and Risk of Early Brain Abnormalities on Magnetic Resonance Imaging at Term among Infants Born at ≤32 Weeks’ Gestational Age

• Published in: The Journal of pediatrics 2024-10, Vol.273, p.114133, Article 114133
• Main Authors: Jain, Shipra, Barnes-Davis, Maria E., Fu, Ting Ting, Sahay, Rashmi D., Ehrlich, Shelley R., Liu, Chunyan, Kline-Fath, Beth, Habli, Mounira, Parikh, Nehal A.
• Format: Article
• Language: English
• Subjects: Adult; Brain - abnormalities; Brain - diagnostic imaging; brain injury; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced - epidemiology; hypertensive disorders of pregnancy; Infant, Newborn; Infant, Premature; Magnetic Resonance Imaging; Male; MRI; preeclampsia; Pregnancy; pregnancy-induced hypertension; preterm infants; Prospective Studies; Risk Factors
• ISSN: 0022-3476; 1097-6833; 1097-6833
• DOI: 10.1016/j.jpeds.2024.114133

To evaluate the proximal effects of hypertensive disorders of pregnancy (HDP) on a validated measure of brain abnormalities in infants born at ≤32 weeks’ gestational age (GA) using magnetic resonance imaging at term-equivalent age. In a multisite prospective cohort study, 395 infants born at ≤32 weeks' GA, underwent 3T magnetic resonance imaging scan between 39 and 44 weeks’ postmenstrual age. A single neuroradiologist, blinded to clinical history, evaluated the standardized Kidokoro global brain abnormality score as the primary outcome. We classified infants as HDP-exposed by maternal diagnosis of chronic hypertension, gestational hypertension, pre-eclampsia, or eclampsia. Linear regression analysis identified the independent effects of HDP on infant brain abnormalities, adjusting for histologic chorioamnionitis, maternal smoking, antenatal steroids, magnesium sulfate, and infant sex. Mediation analyses quantified the indirect effect of HDP mediated via impaired intrauterine growth and prematurity and remaining direct effects on brain abnormalities. A total of 170/395 infants (43%) were HDP-exposed. Adjusted multivariable analyses revealed HDP-exposed infants had 27% (95% CI 5%-53%) higher brain abnormality scores than those without HDP exposure (P = .02), primarily driven by increased white matter injury/abnormality scores (P = .01). Mediation analyses showed HDP-induced impaired intrauterine growth significantly (P = .02) contributed to brain abnormality scores (22% of the total effect). Maternal hypertension independently increased the risk for early brain injury and/or maturational delays in infants born at ≤32 weeks’ GA with an indirect effect of 22% resulting from impaired intrauterine growth. Enhanced prevention/treatment of maternal hypertension may mitigate the risk of infant brain abnormalities and potential neurodevelopmental impairments.